Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?

Ademà V, Hernández JM, Abáigar M, Lumbreras E, Such E, Calull A, Dominguez E, Arenillas L, Mallo M, Cervera J, Marugán I, Tormo M, García F, González T, Luño E, Sanzo C, Martín ML, Fernández M, Costa D, Blázquez B, Barreña B, Marco F, Batlle A, Buño I, Martínez-Laperche C, Noriega V, Collado R, Ivars D, Carbonell F, Vallcorba I, Melero J, Delgado E, Vargas MT, Grau J, Salido M, Espinet B, Melero C, Florensa L, Pedro C, Solé F.

Leuk Res. 2013 Apr;37(4):416-21. doi: 10.1016/j.leukres.2012.12.010. Epub 2013 Jan 18.

PMID:
23337401
2.

[Detection of monosomy 7 or 7q- in cases of myelodysplastic syndrome].

Shen Y, Xue Y, Li J, Guo Y, Pan J, Wu Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Aug;18(4):255-8. Chinese.

PMID:
11484160
4.

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.

Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry.

Cancer. 2012 Jan 1;118(1):127-33. doi: 10.1002/cncr.26279. Epub 2011 Jun 29.

5.
6.

[Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].

Xiao Y, Liu SH, Liu XP, Qin S, Bo LJ, Li CW, Dai Y, Wang JS.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Dec;20(6):471-6. Chinese.

PMID:
14669212
7.

Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?

Galván AB, Mallo M, Arenillas L, Salido M, Espinet B, Pedro C, Florensa L, Serrano S, Solé F.

Leuk Res. 2010 Sep;34(9):1242-5. doi: 10.1016/j.leukres.2010.03.022. Epub 2010 Apr 1.

PMID:
20362335
8.
9.

Masked monosomy 7 in myelodysplastic syndromes is uncommon and of undetermined clinical significance.

Jakovleva K, Ogard I, Arvidsson I, Jacobsson B, Swolin B, Hast R.

Leuk Res. 2001 Mar;25(3):197-203.

PMID:
11226514
10.

Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.

Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, Qian S, Xu W, Xue Y.

Exp Oncol. 2007 Dec;29(4):299-303.

PMID:
18199987
11.
12.

Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.

Kokate P, Dalvi R, Koppaka N, Mandava S.

Cancer Genet. 2017 Oct;216-217:120-127. doi: 10.1016/j.cancergen.2017.05.004. Epub 2017 Aug 16.

PMID:
29025586
13.

Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.

Yilmaz Z, Sahin FI, Kizilkilic E, Karakus S, Boga C, Ozdogu H.

Clin Exp Med. 2005 Jul;5(2):55-9.

PMID:
16096854
14.

Transient monosomy 7: a case series in children and review of the literature.

Mantadakis E, Shannon KM, Singer DA, Finklestein J, Chan KW, Hilden JM, Sandler ES.

Cancer. 1999 Jun 15;85(12):2655-61. Review.

PMID:
10375115
15.

[Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].

Chen LJ, Li JY, Xiao B, Zhu Y, Liu Q, Pan JL, Qiu HR, Fan L, Zhang SJ, Lu RN, Xu W, Xue YQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):635-9. Chinese.

PMID:
18067073
16.

Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).

Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Biondi A, Scherer SW, Kearney L.

Leukemia. 1996 Apr;10(4):644-9.

PMID:
8618441
17.

Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates.

Tanaka K, Arif M, Eguchi M, Shintani T, Kumaravel TS, Asaoku H, Kyo T, Dohy H, Kamada N.

Cancer Genet Cytogenet. 1999 Nov;115(1):32-8.

PMID:
10565297
18.

[Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].

Shen Y, Xue Y, Li J, Pan J, Wu Y, Chen S.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):160-3. Chinese.

PMID:
12673589
19.

Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.

Flactif M, Lai JL, Preudhomme C, Fenaux P.

Leukemia. 1994 Jun;8(6):1012-8.

PMID:
8207974
20.

Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.

Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, García-Cerecedo T, López R, Talavera E, Fernández-Ruiz S, Ademà V, Marugan I, Luño E, Sanzo C, Vallespí T, Arenillas L, Marco Buades J, Batlle A, Buño I, Martín Ramos ML, Blázquez Rios B, Collado Nieto R, Vargas MT, González Martínez T, Sanz G, Solé F; Spanish Group for Mds Study (GESMD); Spanish Group for Clinical Cytogenetics (Gcecgh).

Leuk Lymphoma. 2015;56(11):3183-8. doi: 10.3109/10428194.2015.1028053. Epub 2015 May 12.

PMID:
25754580

Supplemental Content

Support Center